Plasma renin activity in hyper- and hypothyroidism: effect of adrenergic blocking agents.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000804:Angiotensin II / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood* / Q000628:therapy; D007037:Hypothyroidism / Q000097:blood* / Q000188:drug therapy; D010643:Phenoxybenzamine / Q000494:pharmacology* / Q000627:therapeutic use; D011433:Propranolol / Q000494:pharmacology* / Q000627:therapeutic use; D011863:Radioimmunoassay; D012083:Renin / Q000097:blood* / Q000378:metabolism; D013268:Stimulation, Chemical
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010643:Phenoxybenzamine; D000804:Angiotensin II; D011433:Propranolol; D012083:Renin